India scales up testing capacity from 1 in Jan to over 77 mn in Oct: MoHFW

The testing capacity in the country has been ramped up at a significant pace to reach over 77 million in October from just one in January this year, according to MoHFW

Coronavirus, vaccine, covid, drugs, tests, clinical trials
Representative image
ANI General News
2 min read Last Updated : Oct 04 2020 | 8:55 AM IST

The testing capacity in the country has been ramped up at a significant pace to reach over 7.7 crores in October from just one in January this year, according to the Ministry of Health and Family Welfare (MoHFW) on Sunday.

The MoHFW also said that the increased pace of testing has led to "early identification, prompt isolation, and effective treatment of COVID-19 cases. These have eventually resulted in a sustained low Fatality Rate."

"India has scaled up its testing capacity from one in January to more than 7.7 cr in October. With progressively falling positivity rate, testing has worked as an effective tool to limit the spread of COVID-19 infection," a tweet by the MoHFW read.

As per the MoHFW, 7,78,50,403 tests for COVID-19 were conducted in the country on October 3 which marks a new high.

Further the positivity rate in the country is at 8.32 per cent currently, as per the Health Ministry.

With an increase of 1,069 deaths reported on Saturday, the COVID-19 toll surpassed 1 lakh in India, according to the Ministry of Health and Family Welfare (MoHFW).

With the latest increase, the COVID-19 toll in the country now stands at 1,00,842.

Meanwhile, the country reported 79,476 new cases, taking the tally of people infected with coronavirus to 64,73,545, the Ministry said.

The total COVID-19 count includes 9,44,996 active cases and 54,27,707 cured, discharged, or migrated cases.

Meanwhile, the Union Ministry of Health and Family Welfare said that India has maintained the top global ranking with maximum recoveries of COVID-19 patients and it has one of the lowest mortality rates in the world.

The recovery rate of COVID-19 patients now stands at 83.84 per cent and the total recoveries have surpassed the 54 lakh mark.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Oct 04 2020 | 8:50 AM IST

Next Story